 All consecutive consenting patients recently diagnosed 6 months with CTEPH at participating study sites will be enrolled. Patients must meet inclusion criteria and have the diagnosis of CTEPH confirmed by the Adjudication Committee AC to be enrolled. Adult and pediatric patients may be enrolled and prior medical therapy will not exclude patients from enrollment. 